Local modulation of the natriuretic peptide system in the rat remnant kidney

Nephrology Dialysis Transplantation

Volumn 24, Issue 6, 2009, Pages 1774-1782

  Santos Araújo, Carla ^a   Roncon Albuquerque, Roberto ^a   Moreira Rodrigues, Mónica ^a   Henriques Coelho, Tiago ^a   Quelhas Santos, Janete ^a   Faria, Bernardo ^a   Sampaio Maia, Benedita ^a   Leite Moreira, Adelino F ^a   Pestana, Manuel ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

BNP; Chronic renal insufficiency; Heart failure; Hypertension; Natriuretic peptide receptor

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE; HEMODYNAMIC PARAMETERS; IMMUNODETECTION; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PARENCHYMA; KIDNEY TUBULE DISORDER; MALE; MODULATION; NEPHRECTOMY; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; URINALYSIS; WESTERN BLOTTING; WISTAR HANNOVER RAT;

ANIMALS; BASE SEQUENCE; BLOOD VOLUME; CORONARY CIRCULATION; DNA PRIMERS; HEMODYNAMICS; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER;

EID: 67651089868     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn719     Document Type: Article

References (39)

1. Callera G, Tostes R, Savoia C et al. Vasoactive peptides in cardio-vascular (patho)physiology. Expert Rev Cardiovasc Ther 2007; 5: 531-552
2. Bełtowski J, Wójcicka G. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. Med Sci Monit 2002; 8: 39-52
3. Brenner B, Ballermann B, Gunning M et al. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70: 665-699
4. Cogan M. ANF can increase renal solute excretion primarily by raising glomerular filtration. Am J Physiol Ren Fluid Electrolyte Physiol 1986; 250: 22-26
5. Sonnenberg H, Honrath U, Chong C et al. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol Ren Fluid Electrolyte Physiol 1986; 250: 963-966
6. Tremblay J, Desjardins R, Hum D et al. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem 2002; 230: 31-47
7. Van de Stolpe A, Blouch K, Jamison R. Micropuncture study of the effect of ANP on the papillary collecting duct in the rat. Am J Physiol Ren Fluid Electrolyte Physiol 1988; 254: 477-483
8. Melo L, Steinhelper M, Pang S et al. ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 2000; 3: 45-58
9. Oliver P, Fox J, Kim R et al. Hypertension, cardiac hypertrophy and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997; 94: 14730-14735
10. Suganami T, Mukoyama M, Sugawara A et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol 2001; 12: 2652-2663
11. Brown L, Nunez D, Wilkins M. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest 1993; 92: 2702-2712
12. Joffy S, Rosner M. Natriuretic peptides in ESRD. AmJKidneyDis 2005; 46: 1-10
13. Katafuchi T, Mizuno T, Hagiwara H et al. Modulation by NaCl of atrial peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured endothelial cells. JBiolChem 1992; 267: 7624-7629
14. Shi S, Vellaichamy E, Chin S et al. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol 2003; 285: 694-702
15. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol 1992; 54: 11-27
16. Matsukawa N, Grzesik W, Takahashi N et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of natriuretic peptide system. Proc Natl Acad Sci USA 1999; 96: 7403-7408
17. Carrithers S, Taylor B, Cai W et al. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron. Regul Pept 2000; 95: 65-74
18. Kuhn M. Structure, regulation and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 2003; 93: 700-709
19. Garbers D, Chrisman T, Wiegn P et al. Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab 2006; 17: 251-258
20. de Nicola L, Bellizzi V, Cianciaruso B et al. Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients. J Am Soc Nephrol 1997; 8: 445-455
21. Cianciaruso B, Bellizzi V, Minutolo R et al. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol 1996; 7: 306-313
22. Suda S, Weidmann P, Saxenhofer H et al. Atrial natriuretic factor in mild to moderate chronic renal failure. Hypertension 1988; 11: 483-490
23. Tsutamoto T, Kanamori T, Morigami N et al. Possibility of downregulation of natriuretic peptide receptor coupled do guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 1993; 88: 811-813
24. Tsutamoto T, Wada A, Maeda K et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Circulation 1997; 96: 509-516
25. Sagnella G. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci 1998; 95: 519-529
26. Isaac DL. Biomarkers in heart failure management. Curr Opin Cardiol 2008; 23: 127-133
27. Sampaio-Maia B, Serrão P, Guimarães T et al. Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 2005; 99: 46-55
28. Moller J, Jorgensen T, Mortensen J. Proximal tubular atrophy: qualitative and quantitative structural changes in chronic obstructive nephropathy in the pig. Cell Tissue Res 1986; 244: 479-491
29. Martin E, Lewicki J, Scarborough R et al. Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae. Am J Physiol Ren Fluid Electrolyte Physiol 1989; 257: 649-657
30. + reabsorption by ANP 31-67. Clin Exp Pharmacol Physiol 1995; 22: 121-124
31. Matsukawa N, Grzesik W, Takahashi N et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 1999; 96: 7403-7408
32. Tagore R, Ling L, Yang H et al. Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1644-1651
33. Nomora H, Hayashi T, Esaki T et al. Standardization of plasma brain natriuretic peptide concentrations in older Japanese - relationship to latent renal dysfunction and ischemic heart disease. J Am Geriatr Soc 2002; 50: 1504-1509
34. Tsutamoto T, Wada A, Sakai H et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006; 47: 582-586
35. Burke M, Cotts W. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 2007; 12: 23-36
36. Eiskjaer H, Nielsen C, Pedersen E. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans. J Hypertens 1996; 14: 99-106
37. Mark P, Stewart G, Gansevoort R et al. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 402-410
38. Passino C, Poletti R, Fontana M et al. Clinical relevance of non-cardiac determinants of natriuretic peptide levels. Clin Chem Lab Med 2008; 46: 1515-1523
39. Charloux A, Chaouat A, Piquard F et al. Renal hyporesponsiveness to brain natriuretic peptide: both generation and renal activity of cGMP are decreased in patients with pulmonary hypertension. Peptides 2006; 27: 2993-2999